NSEBSE

There is a 15-minute delay in the prices. To check out the live prices, log in to your Ventura account or open one today.

Max

Open1,655.1

High1,790

Low1,614.9

Prev. Close1,594.5

Avg. Traded Price1,743.24

Volume50,52,081

MARKET DEPTH

Total bid514962.00

Total ask155002.00

Orders	Qty	Bid
9	477	1782
1	2	1781.8
1	22	1781.7
2	26	1781.5
1	2	1781.4

Ask	Qty	Orders
1782.1	2	32
1783	5	107
1783.1	4	35
1783.2	3	88
1783.3	4	124

HIGH/LOW

52w

LOW/HIGH

₹1614.902 hours ago

₹1790.0036 minutes ago

LOWER/UPPER CIRCUITS

₹1275.60

₹1913.40

Sai Life Sciences Ltd Stock performance

KEY OBSERVATIONS

positive

negative

neutral

Annual Revenue,rose 29.47%, in the last year to ₹2,241.62 Cr. Its sector's average revenue growth for the last fiscal year was 12.19%.

Annual Net Profit,rose 105.08% in the last year to ₹348.91 Cr. Its sector's average net profit growth for the last fiscal year was 1.94%.

Quarterly Revenue,rose 11.66% YoY to ₹557.83 Cr. Its sector's average revenue growth YoY for the quarter was 16.34%.

About Sai Life Sciences Limited

Sai Life Sciences Limited is a fully integrated Contract Research, Development and Manufacturing Organisation (CRDMO) specialising in small-molecule new chemical entities. Established in 1999, the company began with medicinal chemistry services before evolving into an end-to-end partner for pharmaceutical and biotechnology companies, supporting them across discovery, development, and commercial manufacturing.

Headquartered in Hyderabad, Sai Life Sciences operates large R&D and manufacturing sites in India, with additional laboratories near key innovation hubs in the US (Greater Boston) and the UK (Manchester), ensuring proximity to clients and offering economical scale-up options.

The company caters to a global innovator client base, including 18 of the world’s top 25 pharmaceutical companies by revenue (CY2024). It serves regulated markets such as the US, Europe, and Japan. By maintaining operations across India, the US, and the UK, Sai Life Sciences ensures smooth technology transfers and scale-ups, while manufacturing activities remain India-based.

The company has three subsidiaries (not named) and achieved several milestones, including successful USFDA and PMDA audits at its facilities, expansion of the Bidar site, and investments in research centres in Boston and Manchester. Sai Life Sciences made its public debut with a stock exchange listing on December 18, 2024, when its equity shares commenced trading on the NSE and BSE.

Business Segment of Sai Life Sciences Limited

CRDMO services – 100% of turnover, covering discovery, development, and commercial manufacturing for small molecules.

Sai Life Sciences Limited’s Key Management Team

K. Ranga Raju – Chairman
Krishnam Raju – Managing Director & Chief Executive Officer
Sivaramakrishnan Chittor – Director & Chief Financial Officer
Runa Karan – Company Secretary & Compliance Officer

Latest Updates on Sai Life Sciences Limited

IPO milestone: Sai Life Sciences listed its equity shares on NSE and BSE on December 18, 2024. The IPO was oversubscribed 10.27 times with 39.85 crore bids for 3.87 crore shares. Shares debuted at ₹650 on NSE (18.4% premium) and ₹660 on BSE (20.22% premium).
Strengthened balance sheet: IPO proceeds were used to repay ₹720 crore of debt, reducing leverage and enabling growth flexibility.
Facility upgrades: Established a Peptide Research Center at Unit II and commissioned a High Potency API (HPAPI) manufacturing block at Unit IV, Bidar, to support advanced modalities.
Global footprint: Nearly 97% of revenue comes from international markets, primarily North America, Europe, Japan, and the UK.
Workforce scale: As of March 31, 2025, the company employed 3,401 permanent staff across domestic and international operations.

Similar stocks

SUNPHARMA₹1843.20+14.20 (0.78%)

DIVISLAB₹10156.00+15.50 (0.15%)

TORNTPHARM₹4754.70+44.70 (0.95%)

LAURUSLABS₹2320.30-25.70 (1.10%)

ZYDUSLIFE₹1195.70+2.70 (0.23%)

Grow your wealth with more research recommendations

+91

Frequently Asked Questions

What was today's high for Sai Life Sciences Ltd share?

The intraday high for Sai Life Sciences Ltd on the NSE today (06 Nov 2026) was ₹1,790.00. This compares to the 52-week high of ₹1,697.00 recorded on 09 Sep 2026. Today's high was 5.48% above the 52-week high.

How much return has Sai Life Sciences Ltd given in the last 52 weeks?

Sai Life Sciences Ltd has delivered 72.88% return over the last 52 weeks. During this period, the stock hit a 52-week high of ₹1,697.00 on 09 Sep 2026 and a 52-week low of ₹783.85 on 05 Feb 2026. It is currently trading at ₹1,785.00 as of 06 Nov 2026.

What is the highest Sai Life Sciences Ltd share price ever recorded and when?

The all-time high (ATH) for Sai Life Sciences Ltd was ₹1,675.40, recorded on 09 Sep 2026. At the current price of ₹1,785.00, the stock is trading -6.54% below its all-time high. The all-time low recorded was ₹640.25 on 09 Apr 2025.

What is the share price of Sai Life Sciences Ltd?

As of 06 Nov 2026, the share price of Sai Life Sciences Ltd is ₹1,785.00 on the NSE and ₹1,785.00 on the BSE. The stock opened at ₹1,655.10, touched a high of ₹1,790.00 and a low of ₹1,614.90 during today's session.

How much return has Sai Life Sciences Ltd given in the last 6 months?

Over the last 6 months, Sai Life Sciences Ltd has given a return of 47.75%. The stock was priced at ₹1,079.20 on 06 May 2026 and has Rise to ₹1,785.00 as of 06 Nov 2026, a change of ₹705.80 per share.

What was Sai Life Sciences Ltd's low today on the NSE?

The intraday low for Sai Life Sciences Ltd on the NSE today was ₹1,614.90. The stock's 52-week low stands at ₹783.85, recorded on 05 Feb 2026. Today's low is 106.02% above the 52-week low, indicating the stock is trading well above its yearly lows.

What is the return of Sai Life Sciences Ltd in the past 5 years?

Sai Life Sciences Ltd has delivered a N/A% absolute return over the past 5 years, equivalent to a CAGR of N/A% per annum. The stock was priced at ₹N/A in Nov 2021 and has fallen to ₹1,785.00 as of 06 Nov 2026. An investment of ₹1,00,000 in Sai Life Sciences Ltd five years ago would be worth ₹N/A today.

Has Sai Life Sciences Ltd offered any dividend in the past 5 years?

No,Sai Life Sciences Ltd has not declared any dividend over the past 5 years. The company paid a total dividend of N/A per share between FY2022 and FY2026, with the most recent dividend of ₹N/A per share. At the current market price of ₹1,785.00, the trailing dividend yield of Sai Life Sciences Ltd stands at N/A%.

How much return has Sai Life Sciences Ltd given in the last 3 months?

Sai Life Sciences Ltd has delivered a return of 12.81% over the last 3 months. The stock was trading at ₹1,413.50 on 06 Aug 2026 and is currently at ₹1,785.00 as of 06 Nov 2026, reflecting a Gain of ₹371.50 per share over this period.

What were the most recent reported sales and net income of Sai Life Sciences Ltd?

For Q1 FY27, Sai Life Sciences Ltd reported: Revenue (Net Sales): ₹5467.29 Cr - Down -8.01% year-on-year from ₹5943.40 Cr in Q4 FY26. Net Income (PAT): ₹713.39 Cr - Down -30.42% year-on-year from ₹1025.32 Cr in Q4 FY26.